Table 2—

Comparison between the intervention and reference group: diabetes care received by the patients

Study groupYear before baseline measurementAfter 18 monthsAfter 30 monthsAfter 42 monthsOR (95% CI)*
nIG312312287229
RG77777041
≥4 diabetes visitsIG48.770.268.372.13.58
RG32.539.047.143.9(1.67–7.67)
Measurements
 ≥1 HbA1cIG34.985.370.775.53.61
RG15.644.241.429.3(1.62–8.08)
 ≥1 BPIG68.392.985.084.312.08
RG41.641.640.034.1(4.70–31.01)
 ≥1 TCIG35.387.868.373.44.35
RG10.432.547.129.3(1.81–10.50)
 ≥1 HDL cholesterolIG16.074.462.460.73.11
RG5.227.342.924.4(1.37–7.06)
 ≥1 triglycerideIG17.675.361.059.42.95
RG5.227.342.924.4(1.28–6.82)
 ≥1 serum creatinineIG36.586.269.374.73.80
RG11.733.847.126.8(1.59–9.10)
 ≥1 urine albuminIG17.967.954.753.72.43
RG3.916.937.124.4(1.01–5.82)
 ≥4 weightIG14.439.433.137.13.79
RG2.65.210.012.2(1.04–13.79)
  • Data are n unless otherwise indicated.

  • *

    * Adjusted for sex, age, duration of diabetes, region, treatment, and baseline value.